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FRETSeveral widespread and severe degenerative diseases are characterized by the deposition of amyloid
protein aggregates in affected tissues. While there is great interest in the complete description of the
aggregation pathway of the proteins involved, a molecular level understanding is hindered by the
complexity of the self-assembly process. In particular, the early stages of aggregation, where
dynamic, heterogeneous and often toxic intermediates are populated, are resistant to high-resolu-
tion structural characterization. Fluorescence spectroscopy is a powerful and versatile tool for such
analysis. In this review, we survey its application to provide residue-speciﬁc information about amy-
loid intermediate states for three selected proteins: IAPP, a-synuclein, and tau.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
The pathological self-assembly and deposition of proteins is a
hallmark of a wide variety of devastating human disorders
classiﬁed as protein misfolding or amyloid diseases (reviewed in
[1–3]). These disorders are widespread and severe, encompassing
3 of the top 15 causes of death in the USA (Alzheimer’s disease
(AD), Type II Diabetes Mellitus (T2D) and Parkinson’s disease
(PD)) [4] as well as other major conditions including Chronic
Traumatic Encephalopathy (CTE), Huntington’s disease and Creutz-
feldt-Jakob disease. There is therefore urgent and signiﬁcant clini-
cal interest in understanding the factors that trigger pathological
self-assembly, and the development of pharmacological means
by which this disease-related phenomenonmay be arrested or mit-
igated. Initial efforts to understand the molecular mechanisms of
amyloid diseases focused on characterization of ﬁbrillar aggre-
gates. Since then, however there has been growing interest in thestructures formed along the aggregation pathway (Fig. 1a), investi-
gating the hypothesis that these early structures are relevant to
toxicity and thus are potential targets for therapeutic intervention.
The aggregation of amyloidogenic proteins generally display
nucleation-dependent kinetics, wherein the conversion from
monomer to aggregate displays a lag phase dependent on the accu-
mulation of a nucleus – an on-pathway, high-energy intermediate
that must be populated in order for subsequent self-assembly to
progress. The lag phase is followed by a rapid, cooperative ﬁbril
growth phase until the reaction saturates upon depletion of mono-
mer, and may be reduced in duration or eliminated by the addition
of a small amount of ‘seed’ of preformed amyloid material (Fig. 1b)
[5,6]. This behavior means that the conformation and population of
speciﬁc, transiently-populated intermediates early in the self-
assembly process play major roles in determining the nature and
prevalence of subsequent toxic states. The dynamic and often het-
erogeneous nature of these transient intermediates makes them
highly challenging targets for conventional structural biology ap-
proaches. Indeed, recent years have seen the development and
application of a number of powerful biophysical approaches to
the characterization of intermediates in the self-assembly process
[7]. Signiﬁcant insight has been gained into the thermodynamics
driving aggregation as well as the secondary, tertiary and in some
cases quarternary structures of molecular species relevant to path-
ological self-assembly [8–10].
Fluorescence spectroscopy has a number of advantages for
the characterization of amyloidogenic proteins, including
(a)
(b)
Fig. 1. (a) Conversion of soluble protein to amyloid aggregates. Proteins may convert from their native states or conformational ensembles (i) to an aggregation-prone form
(ii), and then proceed via a population of on-pathway oligomers (iii) to amyloid ﬁbers (iv). Proteins may also form off-pathway oligomers (v), or bind to membranes (vi) in
modes which could inhibit or enhance ﬁber formation. Biologically relevant toxicity could result from states ii, iii, v or vi, while states i and iv are thought to be comparatively
inert. (b) Schematic of aggregation kinetics displayed by amyloidogenic proteins. Sigmoidal ﬁbrillization kinetics are observed in buffer (black) that can be accelerated, in
many cases, by the addition of suitable lipid compositions (blue). The lag phase is bypassed upon the addition of a seed of preformed ﬁbrillar material (red), demonstrating
the nucleation-dependent nature of this process.
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many cases) which inhibits rapid ﬁber formation, as well as en-
abling measurements under conditions (such as bound to mem-
branes or even in cells) that are not easily accessible by other
approaches. The major drawback is a lack of high resolution struc-
tural information relative to techniques such as NMR or EPR. How-
ever, in conjunctionwithmolecular dynamics simulations and other
computational modeling approaches, ﬂuorescence methods can
overcome resolution limitations and generate unique and valuable
insights into the conformation and dynamics of amyloidogenic pro-
teins in monomeric and oligomeric states [7,11,12]. In this review,
we survey selected ensemble and single molecule ﬂuorescence
studies that demonstrate the level of residue-level structural infor-
mation that can be obtained on intermediate species of interest.
Fluorescence approaches to the investigation of amyloidogenic
proteins can be broadly divided into three classes. The ﬁrst capital-
izes on the phenomenon of Förster resonance energy transfer
(FRET), wherein the efﬁciency of non-radiative energy transfer
from a donor ﬂuorophore to an acceptor reports on the distance
between them. FRET measurements may be obtained in steady-
state or time-resolved ensemble formats, or via single molecule
FRET (smFRET; reviewed in [13–16]). Donor and acceptor ﬂuoro-
phores may be placed on the same molecule for intramolecular
FRET, which allows for an assessment of the conformational
ensemble and dynamics of the protein, or may be placed on differ-
ent molecules for intermolecular FRET to interrogate oligomeriza-
tion of the protein. The second class of measurement involves the
site-speciﬁc attachment in the target protein chain of environ-
ment-sensitive ﬂuorophores, so as to probe local environmentand dynamics in aggregation-prone states or through the course
of the aggregation reaction. The third class relies on environ-
ment-sensitive ﬂuorescence from histological and diagnostic dyes
that bind non-covalently to ﬁbers and/or intermediates in the
assembly process, such as Thioﬂavin-T (ThT) and -S (ThS), Congo
Red, Nile Red, and 1-anilinonaphthalene-8-sulfonic acid (ANS)
[17–19]. While there has been recent progress in deﬁning the
structural modes of interaction of these probes with amyloid and
non-amyloid states [20–23], and these methods have generated
fundamental insights into our understanding of pathological self-
assembly, structural information from environment-sensitive dyes
is generally low-resolution and coarse-grained relative to site-spe-
ciﬁc approaches. The use of these dyes also raises the prospect of
false positives [20] and negatives [24] with respect to the existence
of amyloid structure. In this review, we therefore focus on the ﬁrst
two classes of measurement described above, and survey selected
ensemble and single molecule ﬂuorescence studies that demon-
strate the level of residue-level structural information that can
be obtained on intermediate species of interest.
We have selected three amyloidogenic proteins for further
discussion: islet amyloid polypeptide (IAPP; also called amylin),
a-synuclein (AS) and tau. IAPP, AS and tau are implicated in the
pathologies of T2D, PD and AD respectively, and share intriguing
commonalities in terms of toxic mechanism, the nucleated kinetics
of self-assembly, and the importance of electrostatics and tem-
plated self-assembly to the aggregation process. Moreover, they
are all examples of intrinsically disordered proteins (IDPs): in
solution, under physiological conditions, they each sample an
ensemble of diverse, extended conformations rather than folding
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erogeneous nature of the native states of this class of proteins pre-
sents its own set of challenges to biophysical characterization
[7,25,26]. These three proteins differ in native function and size,
spanning a broad range from 37 (IAPP) to 441 (full-length tau) res-
idues, and thus illustrate the versatility of ﬂuorescence approaches
applied to important misfolding diseases. We will describe insights
into the nature of transiently populated aggregation intermediates
populated in solution, the effects of molecular inducers of aggrega-
tion, and the structures of membrane-bound states of these pro-
teins, followed by a discussion of how future advances in
ﬂuorescence methods might impact our understanding of aggrega-
tion-prone states and early oligomers.
2. IAPP
IAPP is a 37-residue, C-terminally amidated, intrinsically disor-
dered peptide hormone secreted by pancreatic islet b-cells
(Fig. 2a). IAPP has proposed functional roles in the satiety response
and the regulation of gastric emptying [27], and is normally pack-
aged into secretory granules along with a 100-fold excess of insu-
lin. In T2D, IAPP is thought to be responsible for the loss of
pancreatic b-cell mass, and is the primary constituent of the char-
acteristic amyloid plaques often observed in T2D patients [28–30].
The in vitro conversion of IAPP from a disordered monomeric
peptide to highly ordered amyloid ﬁbrils has been extensively
studied, typically using light scattering by large aggregates or envi-
ronment-sensitive ﬂuorescence of extrinsic dyes such as ThT as
proxies for the formation of high-order assemblies [32,33]. While
these approaches provide useful information on the thermody-
namics and kinetics of amyloid formation, they do not report on
structural details of oligomeric or ﬁbrillar species. Padrick and
Miranker [34] addressed this deﬁciency in early work by utilizing
the intrinsic ﬂuorescence of the phenylalanine (F15, F23) and tyro-
sine (Y37) residues present in wild-type IAPP. While intrinsic tryp-
tophan ﬂuorescence is a commonly used probe of protein structure
and dynamics, the less intense signals typically observed from
tyrosine and (especially) phenylalanine make their analogous use
comparatively rare in the literature; however, the absence of tryp-
tophan residues in IAPP enabled their use as reporters of conforma-
tion and self-assembly in this case. Based on steady-state
ﬂuorescence measurements, Padrick and Miranker observed FRET
between one or both of the Phe residues and Tyr37 in different(a)
(b)
Fig. 2. (a) Sequence of human IAPP and the rat isoform (rIAPP). The native disulﬁde
bond is indicated with a solid line, and the approximate region of helical structure
upon binding a lipid bilayer is indicated in bold. (b) Representative model of a
membrane-bound rIAPP dimer obtained using intermolecular smFRET measure-
ments [31].stages of the IAPP aggregation reaction. They measured ETeff values
of 0.48 for IAPP in the lag phase and 0.31 for the non-amyloido-
genic rat isoform (rIAPP), indicating mean Phe-Tyr distances of
13 and 14 Å respectively. These values imply that monomeric
IAPP and rIAPP in solution are signiﬁcantly compacted relative to
an ideal random coil (which would display inter-residue distances
of 30 Å for F23-Y37 and 40 Å for F15-Y37), as later conﬁrmed by
tryptophan triplet quenching [35] and hydrodynamic [36,37] mea-
surements. Based on the high energy transfer energy (ETeff) value
of 0.84 observed in ﬁbrillar IAPP, the authors estimated an upper
bound of 11 Å between either Phe and Tyr37 in the mature amyloid
structure. This constraint suggested that ﬁbrillar IAPP assumes a
conformation with at least one turn interrupting stretches with
b-strand character, a prediction validated by subsequent solid-
state NMR [38] and EPR [39] measurements of IAPP ﬁbers. Finally,
the authors used steady-state quenching and anisotropy measure-
ments on Tyr37 to characterize the dynamics of the IAPP C-termi-
nus, and found that this region is highly ordered in the ﬁbrillar
state, with measured anisotropy values close to the fundamental
anisotropy for tyrosine (0.278). Furthermore, the self-assembly ki-
netic measured by changes in steady-state anisotropy closely
matched that measured by ThT ﬂuorescence, suggesting that the
observed increase in order was associated with the acquisition of
b-sheet-rich structure.
An elegant extension of these studies was presented by Marek
et al. [40], based on the introduction of the unnatural amino acid
p-cyanophenylalanine (PheCN) at selected positions in the IAPP se-
quence. The presence of PheCN at positions 15, 23 or 37 of IAPP did
not signiﬁcantly alter ﬁbrillization kinetics as observed by ThT
ﬂuorescence, enabling meaningful site-speciﬁc ﬂuorescence mea-
surements at any one of these residues during the self-assembly
reaction. PheCN ﬂuorescence decreased at all three positions upon
ﬁber formation, a change attributable to either increased FRET to
the remaining aromatic residues in IAPP, a decrease in PheCN ﬂuo-
rescence, or both. Based on relative ﬂuorescence intensities in
ﬁbrillar IAPP, the authors suggested that Phe15 is more solvent-ex-
posed than either Phe23 or Tyr37. While this model is inconsistent
with either the ssNMR- or EPR-derived structures [38,39] of IAPP
ﬁbers, it is possible the discrepancy is due to variations in the
experimental conditions employed for aggregation reactions in
the three different studies.
Membranes play a crucial role in modulating IAPP self-assem-
bly: IAPP binds with high afﬁnity to anionic lipid membranes,
and converts from its disordered solution state to a partially struc-
tured state with increased a-helical structure. This binding dra-
matically catalyzes ﬁber formation, both decreasing the lag time
and increasing the rate of ﬁber growth [41]. NMR measurements
have shown that regions of IAPP assume helical structure upon
binding model membranes, and also transiently sample helical
states in solution [37,42–45]. If these a-helical states are aggrega-
tion intermediates, membrane binding may serve to enhance ﬁber
formation both by increasing the local concentration of IAPP and
by biasing the conformational ensemble towards aggregation-
prone states (Fig. 2).
Another intriguing facet of IAPP-lipid interactions is that IAPP
potently disrupts membranes and causes leakage [46,47]. Evidence
exists in the literature that suggests pore formation and detergent-
like interactions may serve as underlying mechanisms for mem-
brane disruption. Both IAPP and rIAPP have been shown to cause
all-or-none, pore-type leakage in vesicles in a concentration-
dependent manner, with membrane disruption mediated by oligo-
meric species that are formed by stochastic nucleation and evolve
more potent leakage activity above a critical concentration [48].
Alternative models have proposed that Ca2+ potentiates a deter-
gent-like mechanism of membrane disruption [49]. Membrane dis-
ruption by either mechanism may mediate the cytotoxicity
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non-amyloid or pre-amyloid oligomeric states. There is thus con-
siderable interest in the structures of membrane-bound IAPP olig-
omers, but the heterogeneity exhibited by these species at the
protein concentrations (>10 lM) required for NMR, EPR or infrared
spectroscopic approaches complicates structural investigations.
Single-molecule ﬂuorescence approaches provide a powerful
method of dissecting this heterogeneity, while operating at concen-
trations sufﬁciently low to arrest higher-order oligomerization. We
recently applied smFRET to deﬁne the structure of a membrane-
bound rIAPP dimer [31]. Initial measurements on double-labeled
rIAPP indicated a monodisperse, compact ensemble in solution that
underwent a conversion to lower ETeff consistent with the acquisi-
tion of helical structure upon the addition of model membranes, in
excellent accord with previous work [35,37,44]. We then employed
smFRET in an intermolecular format to selectively probe oligomeric
states in a predominantlymonomeric population: separate samples
of rIAPP were labeled with donor and acceptor ﬂuorophores, and
mixed together at pM concentrations in the presence of a model
membrane system (phospholipid bilayer Nanodiscs). A small frac-
tion (0.5%) of rIAPP assembled into membrane-bound dimers
bearing both donor and acceptor ﬂuorophores and thus displayed
high ETeff values, while the remaining particles (rIAPP monomers
either in solution or bound to Nanodiscs) bore only one ﬂuorophore
and thus displayed low apparent ETeff values. The mean ETeff of the
dimeric population reports on the structure of the dimer; ﬁve inde-
pendent inter-residue ETeff values were used to constrain mono-
mer-monomer Monte Carlo docking calculations implemented in
Rosetta [50] to generate low-energy dimer models fully consistent
with experimental measurements, in a procedure roughly analo-
gous to structure determination by NMR. This protocol resulted in
three distinct dimer models that together represent the ﬁrst set of
species formed upon membrane-mediated IAPP self-association.
All three dimer models differed slightly in inter-helical angle and
register, but shared a topology with the N-terminal regions of both
monomers forming a symmetric, antiparallel helix-helix dimer and
the C-termini remaining largely disordered (Fig. 2). It is important
to note that, while the topology of these models is primarily deter-
mined by smFRET constraints, the details of local structure are a
function of the Rosetta reﬁnement procedure. Nevertheless, they
constitute the most detailed structural insight into membrane-
mediated IAPP self-assembly obtained to date, and preliminary
experiments based on ligand design and screening indicate they
may be viable pharmacological targets for the inhibition of IAPP-
mediated cytotoxicity.(a)
(b) (c)
Fig. 3. (a) Schematic of AS sequence, indicating the residues demarcating the N-term
segment that is highly negatively charged at neutral pH and uncharged at low pH. Releva
solution, (c) an extended helix formed upon binding low-curvature lipid bilayers, and (d)3. AS
AS is a 140 amino acid, abundant neuronal protein that is the pri-
mary component of Lewy bodies, the dense cytoplasmic inclusions
found in the substantia nigra of persons suffering from PD. Its pri-
mary sequence consists of three domains: an N-terminal mem-
brane-binding region that contains repeats of the highly conserved
KTKEGV sequence; the hydrophobic NAC central region which con-
tains the minimal aggregation sequence of AS and forms the core of
the ﬁbrillar aggregates; and a highly acidic C-terminal region
(Fig. 3a). Both point mutants of AS (A30P, E46K, and A53T) and mul-
tiplication of the AS gene are linked to familial forms of PD [51–54].
AS has been extensively characterized using smFRET. Because
the putative native function of AS in regulating synaptic vesicles is
thought to involve direct interactions with cellular membranes,
early studies focused on deﬁning the structure of its membrane
bound state.While circular dichroism provided evidence that AS be-
came partially a-helical upon binding membranes [55], and NMR
provided a more detailed view of that structure [56–58], there
was still controversy as to the precise topology of the a-helical re-
gion, with both elongated (Fig. 3c) and horseshoe-shaped (Fig. 3d)
structures proposed. Subramaniam and colleagues published the
ﬁrst smFRET study of AS using the detergent sodium dodecyl sulfate
(SDS) as a membrane mimetic. Labeling AS with donor and acceptor
ﬂuorophores within the membrane binding domain, theymeasured
an intramolecular ETeff compatible with the horseshoe-shaped
model of membrane-bound AS [59]. This was followed shortly after
by work from our own lab where we used both lipid vesicles and
SDS as membrane mimetics. By labeling AS at three different sets
of amino acids spanning various regions within the membrane-
binding domain (residue pairs 9–33, 33–72, and 9–72) we, in agree-
ment with the Subramaniam lab, measured ETeff consistent with a
horseshoe-shaped helix in the presence of SDS. However, upon
binding to more physiological lipid vesicles, we measured an ex-
tended helical conformation [60] which we have also observed for
AS bound to lipid Nanodiscs [61]. The smFRET work conﬁrmed the
ﬁndings of two EPR studies published during the same timeframe
using a variety of lipid mimetics, also found that the curvature of
the mimetic system played a major role in determining the struc-
ture of AS, with the horseshoe found on highly curved, micellar
mimetics, and elongated form dominating on more planar surfaces
[62,63]. A subsequent EPR study indicated that both the horseshoe
and elongated conformations may coexist, in equilibrium, when
bound to certain vesicle systems [64]. This body of work demon-
strates that AS is able to assume different structures in response(d)
inal membrane-binding region, the hydrophobic NAC region, and the C-terminal
nt structural states of AS include (b) a highly dynamic ensemble of states sampled in
a horseshoe-shaped helix formed upon binding high-curvature membrane mimetics.
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With growing evidence supporting a role for AS in membrane
remodeling [65–68], such conformational ﬂexibilitymay be a neces-
sary mechanism for the generation or maintenance of high curva-
ture lipid bilayers. The presence of multiple membrane-bound
conformations also has important implications for membrane-tem-
plated aggregation of AS, which has been observed under certain
conditions with high AS binding density [69–71]; it implies that like
IAPP, a-helical oligomers may be important intermediates for this
aggregation pathway and nucleation of aggregation may reﬂect
the relative populations of the different conformers of AS.
Concurrent with our work, the Deniz lab published a compre-
hensive study mapping out the SDS-induced folding of AS [72].
One important ﬁnding of this study is that AS populates different
conformations as a function of SDS concentration. In agreement
with the previous SDS and vesicle studies, at SDS concentrations
above the critical micelle concentration (SDS) resulted in AS form-
ing the bent horseshoe helix, whereas the extended helix was pop-
ulated at very high SDS concentrations, where the detergent forms
elongated tubular structures. Strikingly, they also found that con-
centrations of SDS below the CMC induced populations of both
horseshoe-shaped and extended helical conformations of AS. In
subsequent work, the SDS folding pathways of the three PD-asso-
ciated point mutants of AS were probed. While E46K and A53T dis-
played very similar behavior to wild-type AS, A30P was found to
never populate the extended a-helical state at sub-CMC SDS con-
centrations [14]. The importance of misfolding or (for IDPs) partial
folding in the amyloid diseases is well-recognized as evidenced by
their classiﬁcation as ‘‘misfolding diseases’’. The A30P variant of AS
binds anionic vesicles weakly compared to wild-type and the other
PD mutants [73], and these data suggest that altered sampling of
a-helical states in the folding pathway may be predictive of this
decreased afﬁnity for lipid bilayers.
Also of interest for AS is the characterization of aggregation
intermediates, in particular those species that are thought to be di-
rectly relevant to toxicity by binding to and disrupting lipid bilay-
ers. Building upon previous work that had established conditions
for forming stable oligomers of AS that were capable of disrupting
lipid vesicles composed of DOPS [74], Subramaniam and co-work-
ers created AS variants containing a single tryptophan at one of 6
locations throughout the protein sequence [75]. Spectral measure-
ments of the oligomers showed signiﬁcant blue-shifting of the
tryptophan ﬂuorescence, indicative of a more hydrophobic envi-
ronment, from tryptophans located in both the N-terminal and
NAC region of the protein relative to the monomer protein. The
two C-terminal tryptophans also exhibited blue-shifted ﬂuores-
cence emission, but to a lesser extent. Upon binding of the oligo-
mers to DOPS vesicles, the emission of three of the four N-
terminal/NAC tryptophans shifted to even shorter wavelengths,
whereas the C-terminal tryptophans were unaffected. As is well-
established for the monomer protein, these results provide evi-
dence of the importance of the N-terminus in mediating mem-
brane-binding of oligomers as well. To compare oligomer and
ﬁber structures, the emission of each tryptophan was measured
in fully aggregated samples. The blue-shift in the NAC region of
the ﬁbers was much greater than that of the indicating a more
tightly-packed, hydrophobic environment in the ﬁbers. The general
degree to which these tryptophans were buried within the core of
the oligomer or the lipid bilayer was conﬁrmed by measuring the
accessibility of the each of the tryptophans to a molecular quench-
er, acrylamide. The oligomers are more structured than the disor-
dered monomer protein, but still ﬂexible enough to allow
conformational rearrangement to accommodate both membrane-
binding and ﬁber formation.
A more recent paper took a similar approach, but used the
extrinsic label dansyl instead of tryptophan as the environmentsensitive probe [76]. Individual dansyl ﬂuorophores were placed
at positions in the N- (residue 7) and C-termini (residue 136), as
well as a positions which are expected to be involved in the ﬁber
core (residues 26 and 100) [77], and their ﬂuorescence emission
was measured during an AS aggregation reaction. Changes in the
core-ﬁber probes followed the kinetics of aggregation as measured
by light scattering and ThT ﬂuorescence, while the dansyl probes
located at either the N- or C-termini showed evidence of a change
in environment preceding ﬁber formation. These terminal probes
are surprisingly sensitive given that they are thought to be disor-
dered in ﬁbers, and indicate that there are conformational changes
in these distal domains of the proteins that precede the core hydro-
phobic interactions that drive ﬁber packing. Both NMR and smFRET
measurements have suggested that long-range interactions be-
tween the N- and C-termini of AS may be important for modulating
self-association and this work ﬁnds evidence that perturbation of
these interactions occur at an early stage in the aggregation path-
way [78–81].
There has also been signiﬁcant effort to simply characterize the
conformational ensemble of AS in solution (Fig. 3b) to understand
how it is altered by conditions that favor aggregation. Time-resolved
intramolecular FRET measurement of AS variants, each containing a
single tryptophan (donor) and a single nitro-tyrosine (acceptor) at
neutral pH were compared with those at acidic pH, a condition
which promotes aggregation of the protein [82]. At pH 7.4, the dis-
tance distributions calculated showed evidence of both very com-
pact and very extended conformations. While the distributions for
A53T were very similar to wild-type AS, A30P showed a loss of com-
pact conformations in the C-terminus, and greater average separa-
tions in the intermediate and extended populations. These
ﬁndings are qualitatively similar to those of the Deniz group which
suggest that the conformational space sampled by A30P is most al-
tered conformational space relative to wild-type protein [14]. Low-
ering the pH to 4.4 had the general effect of increasing the
amplitude of the compact conformations in wild-type AS. The most
notable changewas in the C-terminus of the protein, which revealed
a new, very compact population, as well as contraction of the most
extended conformation to amore compact one. Our own singlemol-
ecule FRET studies of AS at low pH found similar population of more
compact states in the C-terminus of wild-type AS [78]. The en-
hanced aggregation of AS at low pH may be the result in part from
the more compact, hydrophobic character of the C-terminus.
Modeling of the distance distributions obtained in time-re-
solved FRET measurements allows for the extraction of informa-
tion about the dynamics of the protein chain [11]. Work from the
Haas group used this approach to compare the temperature depen-
dence of the conformational ensembles and dynamics of 8 overlap-
ping segments in the N-terminus and NAC domain of AS [83,84].
They found that each sub-domain of the protein behaved as a ran-
dom, disordered chain, with the exception of the NAC region. Spe-
ciﬁcally, this region showed evidence of slowed intramolecular
diffusion and a pronounced conformational bias. At increased tem-
perature, a condition that accelerates aggregation of AS, the NAC
region was again found to behave differently. While all of the
sub-domains probed generally showed a monotonic increase in
their diffusion coefﬁcients with increasing temperature, the mag-
nitude of this change with signiﬁcantly lower for the NAC domain.
These intriguing results emphasize that the potential importance
of intrinsic chain dynamics in the self-association of disordered
protein states – both IDPs as well as partially or fully denatured
globular proteins – is worth further consideration.
4. Tau
The microtubule-associated protein tau is a neuronal IDP up to
441 residues in length (Fig. 4: dependent on alternative splicing)
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clinical relevance because of its presence in intracellular amy-
loid-type deposits called neuroﬁbrillary tangles (NFTs) frequently
observed in the brains of individuals affected by AD [85]. Extracel-
lular amyloid plaques consisting of deposits of the IDP amyloid-b
(Ab) are also observed in AD brains more often than in healthy
brains, and both classes of aggregate are linked to the pathology
of the disease [86]. In addition, tau aggregate formation is associ-
ated with a range of other neurodegenerative disorders termed
‘tauopathies’, including CTE, Pick’s disease and Frontotemporal
Dementia [87,88].
A major trigger of tau aggregation in vivo is thought to be
hyperphosphorylation, i.e., phosphorylation at a large number of
serine and threonine sites throughout the tau sequence, with a
concomitant increase in negative charge [89]. The details of which
speciﬁc regions or phosphorylation site are most responsible for
the increased aggregation propensity are not understood. How-
ever, tau aggregation can be efﬁciently induced in vitro by the
addition of suitable polyanions (such as the molecular inducer
heparin) [90] or the presence of anionic surfaces or interfaces
(including negatively charged lipids and polystyrene micro-
spheres) [91,92]. These diverse effects highlight the importance
of electrostatic effects in modulating the self-assembly behavior
of tau.
As with AS and IAPP, tau is disordered in solution but more
compact than an ideal random coil [93–95], forms amphipathic
helical domains upon membrane binding [96,97], and displays
accelerated aggregation upon membrane binding under some con-
ditions [91,92]. Full-length tau is sufﬁciently large that NMR exper-
iments are highly challenging and require specialized acquisition
and assignment procedures [95,98], and so most spectroscopic
work to date has been performed on shorter constructs of tau. Con-
structs spanning the microtubule-binding region (MTBR; residues
244–369) are potent amyloid-formers; inclusion of the remainder
of the protein signiﬁcantly slows aggregation kinetics, suggesting
that it may be necessary to the full-length protein in order to gain
accurate insight into the thermodynamics and kinetics of tau self-
assembly [99]. Other signiﬁcant regions of full-length tau are the
proline-rich region (PRR; residues 151–243) and the N-terminal
projection domain [100] (Fig. 4a).
Seminal ﬂuorescence studies on the conformation of tau in
solution were performed by Mandelkow and co-workers, based(a)
(b)
Fig. 4. (a) Schematic of tau sequence, indicating the residues that demarcate the proline
from smFRET measurements between residues 244 and 354 as a function of heparin conc
two-state transition upon addition of a molecular inducer of aggregation. (c) Charge-hydr
of this protein are expected to vary widely in their polymer properties and response toon both intrinsic tryptophan ﬂuorescence [101,102] and FRET be-
tween tryptophan residues inserted into the tau sequence and
dye (IAEDANS) moieties ligated via cysteine-maleimide chemistry
[103,104]. Notably, ﬂuorophores were introduced at several differ-
ent residue pairs in tau, including one pair spanning virtually the
complete tau sequence, and two pairs within the central MTBR.
Using steady state measurements, Jeganathan et al. [103] mea-
sured ETeff values for energy transfer from Trp to IAEDANS for
ten residue pairs. Strikingly, they observed FRET between the N-
and C-termini of tau, as well as from the C-terminus to the central
MTBR. This indicates that tau forms a highly compact structure in
solution relative to an ideal random coil, with the N-terminus in
relatively close proximity to (but not necessarily in contact with)
the C-terminus, and the latter close to both the N-terminus and
the MTBR. These ﬁndings constitute the so-called ‘paperclip’ model
of tau, and have been highly inﬂuential in subsequent conforma-
tional studies. One potential caveat with the quantitative interpre-
tation of this work is that the authors converted ETeff values to
inter-residue distances using the canonical form of the Förster
equation instead of convolving the Förster equation with an esti-
mate of the inter-residue distance distribution of a protein chain
(as is necessary and appropriate for accurate interpretation of
FRET-derived for dynamic polymers [105]); another is that ensem-
ble FRET measurements can be highly sensitive to artifacts caused
by incomplete dye labeling. Mandelkow and co-workers subse-
quently used similar ensemble FRET methods [106] to characterize
the relative changes induced by pseudo-phosphorylation (i.e.,
mutations mimicking the added negative charge associated with
phosphorylation) at speciﬁc locations in tau, and found that phos-
phorylation at the ‘AT8’ locus (residues 199, 202 and 205) in-
creased the distance between N- and C-termini, while the ‘PHF1’
locus (residues 396 and 404) decreased the corresponding dis-
tance, and the ‘AT100’ locus (residues 212 and 214) had little ef-
fect. However, combining all three pseudo-phosphorylation
modiﬁcations left the N–C distance relatively unaffected while
decreasing the distances from N- and C-termini to the MTBR. This
study provides a level of qualitative insight into the types of con-
formational changes induced by post-translational modiﬁcations
of tau.
Our group more recently used smFRET to investigate in greater
detail the conformational ensembles populated by tau in the
presence and absence of the aggregation inducer heparin(c)
-rich region (PRR) and microtubule-binding region (MTBR). (b) Contour plot of ETeff
entration, showing that this region of the protein undergoes compaction as a distinct
ophobicity plot of portions of the tau sequence, demonstrating that different regions
changes in the electrostatic environment.
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residues, spanning the sequence, with donor and acceptor dyes
(Alexa Fluors 488 and 594, respectively) and an extensive set of
intramolecular ETeff values were measured in buffer and in various
concentrations of heparin. Computational methodology was also
developed to generate conformational ensembles of IDPs from
these spFRET constraints while rigorously accounting for polymer
chain dynamics and appropriately quantifying the errors intro-
duced at each stage of experiment and analysis. Qualitatively,
our ﬁndings on the conformational ensemble of tau in solution
resembled that of Mandelkow and co-workers [103], in that the
protein chain was signiﬁcantly more compact than an ideal ran-
dom coil, and that long-range interactions brought the N- and C-
termini into relatively close contact. We also detected interactions
between the N-terminus and MTBR that were not reported by Jega-
nathan et al., and also extensively characterized conformation in
the PRR and other regions of tau not studied in the earlier work.
Broadly speaking, heparin induced a compaction in the MTBR
and signiﬁcant expansion through the rest of the protein, suggest-
ing that the heparin-induced aggregation-prone state may be dis-
tinct from the analogous state putatively induced by the pseudo-
phosphorylation mutants. On a quantitative level, the inter-residue
distances derived from our smFRET data were almost universally
larger in magnitude than the corresponding distances from the
data of Jeganathan et al. This discrepancy may be due to the larger
Förster radius of the dye pair we employed (54 Å vs. 22 Å), the
greater sensitivity of single-molecule instrumentation, and/or our
use of appropriate corrections to account for the dynamics of the
tau protein chain.
Two details of our studies with tau highlight particularly well
the unique features of amyloidogenic proteins that are also intrin-
sically disordered. First, the addition of heparin to tau induces a
distinct two-state conformational shift (Fig. 4b), indicating that
heparin is stabilizing or inducing a particular conformation of
tau, rather than mediating a non-speciﬁc transition analogous to
a polymeric coil-globule transition that has been observed in salt
titrations of other disordered proteins [108]. Second, different do-
mains of tau responded differentially to binding of heparin. Further
analysis of the various domains using a net-charge/hydrophobicity
plot (also called an Uversky plot; Fig. 4c) [109] revealed that do-
mains could be classiﬁed in terms of how closely they resemble
canonical globular (high hydrophobicity, low net charge) or intrin-
sically disordered (low hydrophobicity, high net charge) proteins:
the C-terminal sequence (residues 354–433) lies well in the glob-
ular region, the MTBR lies intermediated between disordered and
globular, and the N-terminal projection domain (residues 17–
103) lies far into the disordered part of the map. Each of these do-
mains, then, is predicted to respond differentially to electrostatic
perturbations – a prediction validated by their response to increas-
ing salt concentrations [107]. Importantly, in contrast to globular
proteins whose unfolding can be described by a two-state transi-
tion, the types of continuous conformational changes displayed
by the various regions of tau are better modeled using polymer
physics paradigms [110]. This study highlights the importance of
characterizing multiple domains of the protein in detail in order
to develop a complete picture of the conformational changes rele-
vant to the potentiation of aggregation.
5. Challenges and opportunities: the future of ﬂuorescence
studies of amyloidogenic proteins
The examples discussed above demonstrate how the variety of
ﬂuorescence methodologies available to modern biophysicists,
including ensemble, steady-state and time-resolved approaches,
can be employed to generate powerful insight into the pathologicalself-assembly of amyloid proteins. We have also seen how these
ﬁndings complement the foundational insights from other spectro-
scopic and biochemical methods. However, major questions about
the mechanisms and pathways by which amyloid proteins, partic-
ularly those whose native form is intrinsically disordered, gain
toxic function remain unanswered, and will require the develop-
ment of corresponding new techniques. Here, we outline a few po-
tential areas in which ﬂuorescence-based methods may prove
particularly useful over the next few years.
A variety of modern ﬂuorescence approaches, including ﬂuores-
cence correlation spectroscopy, ﬂuorescence ﬂuctuation spectros-
copy and two-color coincidence detection (TCCD) have been
successfully employed to assess the stoichiometry of oligomeric
intermediates in amyloidogenic pathways [111–118]. However,
obtaining detailed structural insight into these larger species re-
mains challenging. The most promising recent efforts have proba-
bly been from Klenerman and co-workers, who have adapted TCCD
approaches to measure what might be called small-oligomer FRET
[112]. Translating these types of data into useful models could re-
quire improvements in computational techniques to constraint
generation from ambiguous data as well as, potentially, in adapting
concepts from three- and four-color FRET approaches.
Of emerging interest, but not nearly as well-explored as confor-
mational studies, is a role the intrinsic dynamics of unfolded and
disordered proteins in predicting aggregation propensity [119].
Established probes of protein dynamics, such as FRET-FCS [120]
and contact-quenching FCS [121], could be applied to study the dy-
namic behavior of amyloidogenic IDPs under diverse conditions, at
sufﬁciently low concentrations that aggregation ought not to be a
concern. Complementary tools such as time-resolved FRET [11]
could also serve to interrogate the distributions of distances sam-
pled on sub-microsecond timescales.
Finally, the capacity of ﬂuorescence approaches to rapidly char-
acterize amyloidogenic proteins at low concentrations and in het-
erogeneous, complex and biologically relevant environments make
them ideally suited for the screening of conformational modula-
tors. These are drug-like small molecules, peptides or peptidomi-
metics that alter the conformation of a target protein in a
therapeutically useful manner, either inhibiting self-assembly or
inducing the formation of biologically inert oligomeric species.
The sensitivity of ﬂuorescence relative to other spectroscopic tools
allows for the use of much smaller amounts of protein, which is
attractive not just from an economic perspective but also because
it enables the accurate determination of binding constants over a
correspondingly broader dynamic range of modulator afﬁnity.
Fluorescence could thus serve not only to uncover the fundamental
mechanisms and general principles behind pathological protein
self-assembly, but as a route to the discovery and development
of new classes of therapeutic molecules targeting this ubiquitous
and pharmacologically challenging phenomenon.
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